Patent Number: 6,309,826

Title: 88kDa tumorigenic growth factor and antagonists

Abstract: This invention relates to products and methods for treating cancer and for diagnosing tumorigenicity and other diseases associated with alteration in GP88 expression or action. Antagonists to an 88 KDa autocrine growth and tumorigenicity stimulator are provided which inhibit its expression or biological activity. The antagonists include antisense oligonucleotides and antibodies.

Inventors: Serrero; Ginette (Ellicott City, MD)

Assignee:

International Classification: C07K 14/475 (20060101); C07K 14/435 (20060101); C07K 16/22 (20060101); C07K 16/18 (20060101); A61K 38/00 (20060101); C12Q 001/68 (); C12P 019/34 (); C12N 015/11 (); C07H 021/04 ()

Expiration Date: 10/30/2018